Título Abreviado: ECM 22/1844
Investigador Principal: María Díez Campelo
Código EUDRACT:
Código Identificativo: ECI2022/0154

AG946-C-002

A Phase 2a/2b, Open-label, Proof of Concept (Phase 2a) and Double-blind, Randomized, Placebo-Controlled (Phase 2b), Multicenter, Efficacy, and Safety Study of AG-946 in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes

Estado: ACTIVO

Pin It en Pinterest